Irish health minister ploughs extra Euros1m into cardiac surgery:
This article was originally published in Clinica
Executive Summary
The Irish health minister Micheal Martin yesterday announced plans to spend around Euros1m ($1.2m) to boost cardiac surgery at Our Lady's Hospital for Sick Children, in Crumlin (Dublin). The investment will enable the hospital to utilise some of the capacity of its new operating theatre department to perform a minimum of two additional heart operations a week, said the minister during the official opening of this Euros30m unit. He also announced developments in magnetic resonance imaging (MRI), haematology, oncology and cardiac care, planned as "priority interim projects", pending the redevelopment of the whole hospital.
You may also be interested in...
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.
First Off The Blocks, Fresenius Launches US Tocilizumab Biosimilar
Fresenius Kabi has kicked off competition to Genentech’s Actemra in the US, launching its Tyenne biosimilar version of tocilizumab.